The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $170.77

Today's change+5.40 +3.27%
Updated August 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $170.77

Today's change+5.40 +3.27%
Updated August 27 4:00 PM EDT. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC up sharply

Jazz Pharmaceuticals PLC closed up sharply Thursday, rallying (U.S.)$5.40 or 3.27% to (U.S.)$170.77. Shares have lost 6.02% over the last five days, but have gained 4.30% over the last year to date. This security has outperformed the S&P 500 by 5.32% during the last year.

Key company metrics

  • Open(U.S.) $167.87
  • Previous close(U.S.) $165.37
  • High(U.S.) $171.90
  • Low(U.S.) $167.14
  • Bid / Ask-- / --
  • YTD % change+4.30%
  • Volume475,992
  • Average volume (10-day)519,063
  • Average volume (1-month)503,765
  • Average volume (3-month)439,261
  • 52-week range(U.S.) $137.34 to (U.S.) $194.73
  • Beta0.70
  • Trailing P/E64.05×
  • P/E 1 year forward17.11×
  • Forward PEG0.89×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.67
Updated August 27 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue334309328307
Total other revenue--------
Total revenue334309328307
Gross profit--281299280
Total cost of revenue22282927
Total operating expense180193198249
Selling / general / administrative10711210494
Research & development28272597
Depreciation / amortization24253231
Interest expense (income), net operating--------
Unusual expense (income)17190
Other operating expenses, total--------
Operating income15311713058
Interest income (expense), net non-operating-16-16-17-15
Gain (loss) on sale of assets--------
Other--------
Income before tax11910311550
Income after tax88718226
Income tax, total31323424
Net income88718226
Total adjustments to net income--------
Net income before extra. items--718226
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items--718226
Inc. avail. to common incl. extra. items88718226
Diluted net income--718226
Dilution adjustment--------
Diluted weighted average shares63637263
Diluted EPS excluding extraordinary itemsvalue per share--1.121.130.41
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share--1.131.290.26